companydata.dkONCONOX ApS: Financial statements 2020
CVR: 33858965
ONCONOX ApS (CVR 33858965) has filed annual accounts for 2020. In 2020, the company reported a net result of DKK -12,598 compared with DKK -65,962 the year before. Equity amounted to DKK 633. The solvency ratio was 1.1%.
- Profit/Loss
- -12,598 kr.
- Equity
- 633 kr.
- Total Assets
- 55,206 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | - | -13 t. | 633 | - |
| 2019 | - | - | -66 t. | -37 t. | - |
| 2018 | - | 0 | -1 mio. | 29 t. | - |
| 2017 | - | 547 t. | 393 t. | 1.1 mio. | - |
| 2016 | - | 0 | -15 t. | 995 t. | - |
How creditworthy is ONCONOX ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
ONCONOX ApS has published its annual report for 2019. The net result was DKK -65,962.
As of August 19, 2020, Bo Danner Henriksen is registered as director of ONCONOX ApS.
As of August 19, 2020, Ferdinando Nicoletti has stepped down as director of ONCONOX ApS.
About ONCONOX ApS
ONCONOX ApS was a Danish company of the type Anpartsselskab based in Greve, founded in 2011. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company is owned by Amme Pharmaceuticals, Inc.. The company has 0 employees. In 2022, the company reported a net result of DKK -40,672 compared with DKK -43,846 the year before. Equity amounted to DKK -4,305.